Related Experiment Video

Updated: Jun 4, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients

Aoife G Cotter1, Claudette S Satchell, Jane A O'halloran

  • 1HIV Molecular Research Group, School of Medicine and Medical Science, University College Dublin, Ireland. aoife.cotter@ucdconnect.ie

AIDS (London, England)
|February 19, 2011
PubMed

Insights

High-density lipoprotein cholesterol (HDL-c) significantly impacts cardiovascular disease (CVD) risk in HIV patients. Increasing HDL-c levels can effectively lower predicted CVD risk, highlighting its importance in managing patient health.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a major concern for HIV-infected individuals.
  • Understanding the specific risk factors contributing to CVD in this population is crucial for effective management.

Purpose of the Study:

  • To quantify the contribution of high-density lipoprotein cholesterol (HDL-c) to CVD risk.
  • To assess the impact of increasing HDL-c levels on CVD risk reclassification in HIV patients.

Main Methods:

  • Analysis of CVD risk factors in a cohort of HIV-infected patients.
  • Modeling the effect of a 20% and 40% increase in HDL-c on predicted CVD risk.
  • Evaluating the reclassification of patients into lower CVD risk categories.

Main Results:

  • HDL-c was identified as a major contributor to overall cardiovascular risk, second only to age.
  • Increasing HDL-c by 20% reclassified six patients to lower CVD risk groups.
  • A 40% increase in HDL-c reclassified 12 patients to lower CVD risk groups.
  • HDL-c demonstrated a greater impact on CVD risk than smoking, total cholesterol, systolic blood pressure, and sex in this cohort.

Conclusions:

  • HDL-c plays a significant role in determining CVD risk among HIV-infected individuals.
  • Strategies aimed at increasing HDL-c levels may be beneficial in reducing the cardiovascular burden in this patient group.
  • Further research into HDL-c modulation for CVD prevention in HIV is warranted.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...